NS Pharma
CompanyUnited States
NS Pharma develops one asset, in phase 2 (NS-863 in pulmonary arterial hypertension). Mostly small molecule; based in the United States.
- 1
- Asset
- Furthest stage
- Phase 2
- 1
- Trial
- 2
- Signals
Pipeline
1Phase 2, Small molecule, pulmonary arterial hypertension
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Signals3
- Similar companies6